title: Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
authors.affiliation: Center for Epidemiological Research in South Africa, Medical Research Council, Congella. dilraja@mrc.ac.za
authors.forename: A
authors.initials: A
authors.lastname: Dilraj
authors.forename: F T
authors.initials: FT
authors.lastname: Cutts
authors.forename: J V
authors.initials: JV
authors.lastname: Bennett
authors.forename: J
authors.initials: J
authors.lastname: Fernandez de Castro
authors.forename: B
authors.initials: B
authors.lastname: Cohen
authors.forename: H M
authors.initials: HM
authors.lastname: Coovadia
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007117:Immunization, Secondary; D007279:Injections, Subcutaneous; D008297:Male; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000276:immunology*; D008459:Measles virus / Q000276:immunology*; D013997:Time Factors
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine